company background image
SINT

Sintx TechnologiesNasdaqCM:SINT Stock Report

Last Price

US$0.59

Market Cap

US$14.7m

7D

-10.7%

1Y

-66.2%

Updated

16 Jan, 2022

Data

Company Financials +
SINT fundamental analysis
Snowflake Score
Valuation1/6
Future Growth2/6
Past Performance0/6
Financial Health6/6
Dividends0/6

SINT Stock Overview

Sintx Technologies, Inc., an advanced materials company, researches, develops, manufactures, and commercializes silicon nitride ceramics in the United States, Europe, and South America.

Sintx Technologies Competitors

Medtronic

NYSE:MDT

US$146.0b

Stryker

NYSE:SYK

US$100.6b

Zimmer Biomet Holdings

NYSE:ZBH

US$26.6b

Smith & Nephew

LSE:SN.

UK£11.1b

Price History & Performance

Summary of all time highs, changes and price drops for Sintx Technologies
Historical stock prices
Current Share PriceUS$0.59
52 Week HighUS$3.44
52 Week LowUS$0.56
Beta2
1 Month Change-14.46%
3 Month Change-52.82%
1 Year Change-66.22%
3 Year Change-90.52%
5 Year Change-99.62%
Change since IPO-100.00%

Recent News & Updates

Shareholder Returns

SINTUS Medical EquipmentUS Market
7D-10.7%-1.2%-0.5%
1Y-66.2%3.8%13.7%

Return vs Industry: SINT underperformed the US Medical Equipment industry which returned 3.8% over the past year.

Return vs Market: SINT underperformed the US Market which returned 13.7% over the past year.

Price Volatility

Is SINT's price volatile compared to industry and market?
SINT volatility
SINT Average Weekly Movement10.3%
Medical Equipment Industry Average Movement8.2%
Market Average Movement6.6%
10% most volatile stocks in US Market15.9%
10% least volatile stocks in US Market2.4%

Stable Share Price: SINT is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 10% a week.

Volatility Over Time: SINT's weekly volatility has decreased from 15% to 10% over the past year.

About the Company

FoundedEmployeesCEOWebsite
199632B. Balhttps://www.sintx.com

Sintx Technologies, Inc., an advanced materials company, researches, develops, manufactures, and commercializes silicon nitride ceramics in the United States, Europe, and South America. It offers ceramic based solutions for various medical, industrial, and antipathogenic applications. The company provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products.

Sintx Technologies Fundamentals Summary

How do Sintx Technologies's earnings and revenue compare to its market cap?
SINT fundamental statistics
Market CapUS$14.69m
Earnings (TTM)-US$8.91m
Revenue (TTM)US$557.00k

26.4x

P/S Ratio

-1.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
SINT income statement (TTM)
RevenueUS$557.00k
Cost of RevenueUS$417.00k
Gross ProfitUS$140.00k
ExpensesUS$9.05m
Earnings-US$8.91m

Last Reported Earnings

Sep 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)-0.36
Gross Margin25.13%
Net Profit Margin-1,599.10%
Debt/Equity Ratio2.6%

How did SINT perform over the long term?

See historical performance and comparison

Valuation

Is Sintx Technologies undervalued compared to its fair value and its price relative to the market?

0.76x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate SINT's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate SINT's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: SINT is unprofitable, so we can't compare its PE Ratio to the US Medical Equipment industry average.

PE vs Market: SINT is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate SINT's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: SINT is good value based on its PB Ratio (0.8x) compared to the US Medical Equipment industry average (3.5x).


Future Growth

How is Sintx Technologies forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

-7.0%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: SINT is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: SINT is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: SINT is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: SINT's revenue (66.5% per year) is forecast to grow faster than the US market (9.3% per year).

High Growth Revenue: SINT's revenue (66.5% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if SINT's Return on Equity is forecast to be high in 3 years time


Past Performance

How has Sintx Technologies performed over the past 5 years?

8.0%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: SINT is currently unprofitable.

Growing Profit Margin: SINT is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: SINT is unprofitable, but has reduced losses over the past 5 years at a rate of 8% per year.

Accelerating Growth: Unable to compare SINT's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: SINT is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (51.2%).


Return on Equity

High ROE: SINT has a negative Return on Equity (-46.29%), as it is currently unprofitable.


Financial Health

How is Sintx Technologies's financial position?


Financial Position Analysis

Short Term Liabilities: SINT's short term assets ($18.1M) exceed its short term liabilities ($3.2M).

Long Term Liabilities: SINT's short term assets ($18.1M) exceed its long term liabilities ($2.5M).


Debt to Equity History and Analysis

Debt Level: SINT has more cash than its total debt.

Reducing Debt: SINT's debt to equity ratio has reduced from 73.2% to 2.6% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: SINT has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: SINT has sufficient cash runway for 1.5 years if free cash flow continues to reduce at historical rates of 3.1% each year.


Dividend

What is Sintx Technologies's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate SINT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate SINT's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if SINT's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if SINT's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of SINT's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

6.7yrs

Average management tenure


CEO

B. Bal (59 yo)

7.25yrs

Tenure

US$487,442

Compensation

Dr. B. Sonny Bal, M.D., J.D., MBA, PhD, has been the Chief Executive Officer and President of Sintx Technologies, Inc. (formerly known as Amedica Corporation) since October 2014 and its Chairman since Augu...


CEO Compensation Analysis

Compensation vs Market: B.'s total compensation ($USD487.44K) is about average for companies of similar size in the US market ($USD578.13K).

Compensation vs Earnings: B.'s compensation has increased whilst the company is unprofitable.


Leadership Team

Experienced Management: SINT's management team is seasoned and experienced (6.7 years average tenure).


Board Members

Experienced Board: SINT's board of directors are considered experienced (7.6 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Sintx Technologies, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Sintx Technologies, Inc.
  • Ticker: SINT
  • Exchange: NasdaqCM
  • Founded: 1996
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Implied Market Cap: US$14.689m
  • Shares outstanding: 24.71m
  • Website: https://www.sintx.com

Number of Employees


Location

  • Sintx Technologies, Inc.
  • 1885 West 2100 South
  • Salt Lake City
  • Utah
  • 84119
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/01/16 23:23
End of Day Share Price2022/01/14 00:00
Earnings2021/09/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.